(MENAFN- GlobeNewsWire - Nasdaq) Pune, India, March 09, 2023 (GLOBE NEWSWIRE) -- In June 2019, Abbott launched the Afinion HbA1c assay, which is the first and only rapid point-of-care test to aid in the diagnosis of diabetes. haemoglobin a1c (hba1c) test is highly recommended to determine the risk of developing diabetes. The test plays substantial role in taking diabetes treatment and monitoring decisions. However, it has diagnostic limitations for gestational diabetes, diabetes in children, or if a person has anaemia or any other blood disorder. Haemoglobin A1c levels between 5.7% and 6.4% indicates the person has a higher chance of getting diabetes, and the levels of 6.5% and higher indicates the person has diabetes. Various methods for measuring HbA1c include ion-exchange chromatography, electrophoretic methods, mass spectroscopy, reversed-phase HPLC, and electrospray iontophoresis.
The rising prevalence of diabetes is primarily expected to drive the grwoth of the haemoglobin A1c testing devices market during the forecast period. Moreover, increasing emphasis on preventive care coupled with higher accuracy offered by HbA1c testing devices for diabetes diagnosis is anticipated to offer significant growth opporunity for the market. However, the high cost of the devices and lack of product awareness in emerging nations is projected to hamper the market growth during the forecast period.
This information is given by Fortune Business InsightsTM in an upcoming report, titled,“ Haemoglobin A1c Testing Devices Market 2023-2030.”
Request a free sample PDF Brochure
Haemoglobin A1c Testing Devices Market Industry Developments-
In March 2019, Beckmann Coulter launched Automated Microplate System which helps in more accurate diabetes diagnosis.
In June 2016, Randox Laboratories launched Acusera Liquid HbA1c Control with an aim to reduce sample preparation time and is cost effective.
The report covers the following key insights:
Prevalence of diabetes for key countries or key regions,2018 New product launches in haemoglobin a1c testing devices market Technological advancements in global haemoglobin a1c testing devices market Recent industry developments such as partnerships, mergers, and acquisitions
To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit :
The Haemoglobin A1c testing devices market is being driven by several factors, including:
Increasing prevalence of diabetes: The rising incidence of diabetes globally is a major driver for the haemoglobin A1c testing devices market. Haemoglobin A1c testing is used to diagnose and monitor diabetes, which has become a growing concern due to unhealthy lifestyle habits and an aging population.
Advancements in technology: The development of advanced haemoglobin A1c testing devices, such as point-of-care testing (POCT) and handheld devices, has made it easier for patients and healthcare professionals to monitor diabetes. These devices provide quick and accurate results, reducing the need for traditional laboratory-based testing.
Growing demand for homecare testing: The growing trend towards homecare testing has created a significant opportunity for haemoglobin A1c testing devices market. Patients can now monitor their diabetes at home, allowing them to adjust their diet and medication accordingly.
Increased government initiatives: Governments around the world are investing in diabetes management programs and promoting the use of haemoglobin A1c testing devices. For instance, in the US, the Centers for Disease Control and Prevention (CDC) recommends the use of haemoglobin A1c testing for diabetes diagnosis and monitoring.
Rise in healthcare expenditure: The increasing healthcare expenditure in developing and developed countries is also contributing to the growth of the haemoglobin A1c testing devices market. As healthcare systems strive to provide efficient and cost-effective care, haemoglobin A1c testing devices offer a reliable and economical option for diabetes management.
In summary, the haemoglobin A1c testing devices market is expected to grow rapidly due to the increasing prevalence of diabetes, advancements in technology, and government initiatives to promote diabetes management programs. The trend towards homecare testing and rising healthcare expenditure are also key drivers for the market.
The report consists of the profiles of key players, which include several players, including :
F. Hoffmann-La Roche AG Abbott Siemens Healthcare GmbH Beckman Coulter Inc Danaher Bayer AG Bio-Rad Laboratories Inc Thermo Fisher Scientific Inc Trinity Biotech Others
Quick Buy - Haemoglobin A1c Testing Devices Market Research Report:
The Haemoglobin A1c Testing Devices Market is growing globally, with North America, Europe, Asia-Pacific, and the rest of the world being the key regions. Here is a brief regional analysis:
North America: North America is currently the largest market for haemoglobin A1c testing devices due to the high prevalence of diabetes, favorable government initiatives, and technological advancements. The US is the major contributor to the North American market growth.
Europe: The European market for haemoglobin A1c testing devices is driven by increasing diabetes prevalence, increasing healthcare expenditure, and growing awareness among people regarding diabetes management.
Asia-Pacific: Asia-Pacific is expected to be the fastest-growing market for haemoglobin A1c testing devices due to the increasing patient pool, rising geriatric population, and increasing government initiatives to promote diabetes management programs.
Rest of the world: The rest of the world market for haemoglobin A1c testing devices is expected to experience significant growth due to increasing awareness among people about diabetes management and rising healthcare expenditure in developing countries.
In summary, the demand for haemoglobin A1c testing devices is increasing globally due to various factors, and the market is expected to grow rapidly in the coming years. The growth rate may vary across different regions based on factors such as diabetes prevalence, government policies, and technological advancements.
Haemoglobin A1c Testing Devices Market Segmentation :
By Type
Assay Immunoassay Direct Enzymatic Assay Chromatography Reversed phase HPLC Ion-exchange chromatography Boronate affinity chromatography Others
By End User
Hospitals Diagnostic Laboratories Home care settings Others
By Geography
North America (USA and Canada) Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe) Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific) Latin America (Brazil, Mexico and Rest of Latin America) Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Ask for Customization of this Report:
Table Of Contents :
Introduction Research Scope Market Segmentation Research Methodology Definitions and Assumptions
Executive Summary Market Dynamics Market Drivers Market Restraints Market Opportunities
Key Insights Global Statistics - Key Countries New Product Launches Pipeline Analysis Regulatory Scenario - Key Countries Recent Industry Developments - Partnerships, Mergers and Acquisitions
Global Analysis, Insights and Forecast Key Findings/ Summary Market Analysis - By Product Type Market Analysis - By Distribution Channel Market Analysis - By Countries/Sub-regions
Competitive Analysis Key Industry Developments Global Market Share Analysis Competition Dashboard Comparative Analysis - Major Players
Company Profiles Overview Products and Services SWOT Analysis Recent developments Major Investments Regional Market Size and Demand
Strategic Recommendations
TOC Continued...!
Discover more research Reports on healthcare industry , by Fortune Business Insights :
critical care antiarrhythmic drugs market Size, Share, Growth & Report, 2027
spinal muscular atrophy treatment market Size, Share Report, 2026
vagus nerve stimulation market Size, Share, Trends | Report, 2026
pneumonia testing market Size, Share, Growth | Share Statistics [2029]
ultrasound equipment market Size, Share, Growth | Global Report [2028]
About Us:
Fortune Business InsightsTM delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Contact Us:
Fortune Business InsightsTM Pvt. Ltd.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email:
Tags haemoglobin a1c testing device haemoglobin a1c testing testing device market medical device medical device market Related Links specialty enzymes market veterinary chemistry analyzers market laparoscopic surgical procedures market chronic kidney disease treatment market proteinase k market veterinary infusion pump market hernia repair devices market surgical lasers market anesthesia information management systems market condylar plate fixation system market lung cancer surgical treatment market stereotactic body radiation therapy market drugs of abuse testing market tumour ablation devices market non-ionizing radiation market protein labelling market pemphigus vulgaris treatment market companion animal healthcare market sexually transmitted diseases testing market feed antibiotics market